Restoration

EP3609495

NK1-ANTAGONIST COMBINATION AND METHOD FOR TREATING SYNUCLEINOPATHIES

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    9.4.2018
  • :
    24.7.2024
  • :
    18785191.0
  • :
    8.4.2038
  • :
    NK1-ANTAGONIST COMBINATION AND METHOD FOR TREATING SYNUCLEINOPATHIES

9.4.2018
24.7.2024
  • :
    Chase Therapeutics Corporation
  • :
    1825 K Street N.W. Suite 520, Washington, DC 20006, US
  • :
    CHASE, Thomas N.
  • :
    Washington, District of Columbia 20006, US
  • :
    CLARENCE-SMITH, Kathleen E.
  • :
    Washington, District of Columbia 20006, US
  • :
    201762483555 P
  • :
    10.4.2017
  • :
    US
  • :
    US2018026699
  • :
    9.4.2018
  • :
    A61K 31/675, A61K 31/5377, A61K 31/428, A61P 25/00, A61P 25/16, A61P 25/28